England’s NICE Wants Industry Involvement In HTA Sandbox Projects

Pharmaceutical companies are being encouraged to reach out to NICE in relation to its HTA Innovation Lab, which provides a sandbox environment in which the health technology assessment body can test new methods of evaluating “innovative and disruptive” therapies.

Philip Morgan, Andrew Champion, Jamie Elvidge and Jeanette Kusel at the NICE annual conference 2025 (Norstella)
Key Takeaways
  • NICE says that industry plays a crucial role in its projects under the Health Technology Assessment Innovation Lab, a sandbox environment for testing new methods and processes.
  • The HTA Lab is looking at a range of projects, including disease-modifying Alzheimer’s therapies.
  • NICE selects projects by using horizon scanning to discover “disruptive” therapies that are one to two years away from the HTA process.

Industry participation in an HTA sandbox run by England’s health technology assessment (HTA) institute, NICE, is “really crucial” to ensure that the tool is “asking the right questions and testing...

This was the message from NICE’s senior scientific advisor, Jamie Elvidge, who was speaking at NICE’s annual conference on 27 March about the institute’s HTA Innovation Laboratory (HTA Lab).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Health Technology Assessment

More from Market Access

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By 

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.